FEATURED COMPANIES
- Abbott Laboratories
- Autobio Diagnostics Co
- Bruker Corporation
- Carl Zeiss AG
- HiMedia Laboratories
- Merck Millipore
The Global Blood Culture Test Market is estimated to be USD 4.2 Bn in 2021 and is expected to reach USD 6.5 Bn by 2026, growing at a CAGR of 9%.
Though, the unavailability of skillful specialists & laboratory technicians and the high cost of automated blood culture instruments are anticipated to hinder the growth of the market.
By Product, the market is classified as Consumables, Instruments, and Software & Services. Amongst all, the Consumables segment is estimated to hold the highest market share during the forecast period.
By Method, the market is classified as Conventional Methods and Automated Methods. Amongst the two, the Conventional Methods segment is estimated to hold the highest market share during the forecast period.
By Technology, the market is classified as Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-Fish (Peptide Nucleic Acid - Fluorescent In Situ Hybridization), and Proteomics Technology. The Molecular Technologies segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified as Bacteremia, Fungemia, and Mycobacterial Detection. Amongst all, the Mycobacterial Detection segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, and Others. The Hospital Laboratories segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
2. Bruker has Introduced MBT Sepsityper Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures on the MALDI Biotyper CA System– 4th January 2021
Market Dynamics
The major factor leading the growth of the global blood culture test market is the upsurge in the prevalence of infectious diseases such as sepsis, meningitis, osteomyelitis, pneumonia, etc. In addition, an increase in the geriatric population, raising awareness of diagnosis, and increasing public and private healthcare expenditure have escalated the market growth. Developing demand for point-of-care and rapid diagnostic tests, and increasing acceptance of new technologies are escalating the market growth. The market is presumed to observe substantial growth because of technological advancements in terms of automation, cost-effectiveness, and product innovation.Though, the unavailability of skillful specialists & laboratory technicians and the high cost of automated blood culture instruments are anticipated to hinder the growth of the market.
Market Segmentation
The Global Blood Culture Test Market is segmented further based on Product, Method, Technology, Application, End-User, and Geography.By Product, the market is classified as Consumables, Instruments, and Software & Services. Amongst all, the Consumables segment is estimated to hold the highest market share during the forecast period.
By Method, the market is classified as Conventional Methods and Automated Methods. Amongst the two, the Conventional Methods segment is estimated to hold the highest market share during the forecast period.
By Technology, the market is classified as Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-Fish (Peptide Nucleic Acid - Fluorescent In Situ Hybridization), and Proteomics Technology. The Molecular Technologies segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified as Bacteremia, Fungemia, and Mycobacterial Detection. Amongst all, the Mycobacterial Detection segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, and Others. The Hospital Laboratories segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. bioMérieux had received FDA clearance to extend platelet shelf life to 7 days with a Large Volume Delayed Sampling strategy using BACT/ALERT 3D and BACT/ALERT VIRTUO culture systems. - 25th May 20202. Bruker has Introduced MBT Sepsityper Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures on the MALDI Biotyper CA System– 4th January 2021
Company Profiles
Some of the companies covered in this report are Becton, Dickinson, and Company, Agilent, Biobase Biotech (Jinan), bioMérieux, Bruker, Carl Zeiss, Danaher, etc.Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Why buy this report?
- The report offers a comprehensive evaluation of the Global Blood Culture Test Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Blood Culture Test Market
What is the estimated value of the Global Blood Culture Test Market?
What is the growth rate of the Global Blood Culture Test Market?
What is the forecasted size of the Global Blood Culture Test Market?
Who are the key companies in the Global Blood Culture Test Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Autobio Diagnostics Co
- Bruker Corporation
- Carl Zeiss AG
- HiMedia Laboratories
- Merck Millipore
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Blood Culture Test Market, By Product
7 Global Blood Culture Test Market, By Method
8 Global Blood Culture Test Market, By Technology
9 Global Blood Culture Test Market, By Application
10 Global Blood Culture Test Market, By End User
11 Global Blood Culture Test Market, By Geography
12 Competitive Landscape
13 Company Profiles
14 Appendix
Note: Product cover images may vary from those shown
- Anaerobe Systems
- Axiom Laboratories
- Autobio Diagnostics Co
- Becton, Dickinson, and Company
- Agilent Technologies, Inc.
- Biobase Biotech (Jinan) Co.Ltd.
- Bruker Corporation
- Bulldog Bio, Inc.
- Carl Zeiss AG
- Danaher Corporation
- HiMedia Laboratories
- Luminex Corporation
- Meditech Technologies India Pvt Ltd
- OpGen
- Abbott Laboratories
- Scenker Biological Technology Co., Ltd
- T2 Biosystems
- Thermo Fisher Scientific
- Mindray Medical International Limited
- Siemens Healthineers AG
- Merck Millipore
- Perkin Elmer Inc.
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
Note: Product cover images may vary from those shown